XLON
CSN
Market cap1.01bUSD
Oct 09, Last price
322.00GBP
1D
-0.75%
1Q
-1.49%
Jan 2017
-9.65%
IPO
197.97%
Name
Chesnara PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chesnara plc, encompassing its various operating companies, specializes in providing life insurance and pension services, primarily serving clients in the United Kingdom, the Netherlands, and Sweden. The firm conducts its business through several key divisions: CA, Movestic, Waard Group, and Scildon. Chesnara offers coverage for life-related eventualities such as death, disability, health issues, and accidents. Additionally, it manages a diverse portfolio of investment contracts designed to meet customers' savings and retirement objectives through asset management, and also provides general insurance products. Its offerings are mainly distributed via independent financial advisers. Chesnara plc was founded in 2003 and its main office is situated in Preston, UK.
Related entities
Subsidiaries (11)
CASFS LTD
CASLPTS LTD
COUNTRYWIDE ASSURED LIFE HOLDINGS LIMITED
COUNTRYWIDE ASSURED PLC
COUNTRYWIDE ASSURED SERVICES LIMITED
COUNTRYWIDE ASSURED TRUSTEE COMPANY LIMITED
Movestic Livforsakring AB
SCILDON N.V.
Waard Schade N.V.
Movestic Fonder AB
Robein Effectendienstverlening N.V.
Key people
Peter W. Mason
Non-Executive Independent Chairman of the Board · since 2009
John Deane
Chief Executive Officer, Executive Director · since 2015
Frank Hughes
Business Services Director, Executive Director
David Rimmington
Finance Director, Executive Director · since 2013
Zoe Kubiak
Company Secretary · since 2015
David Brand
Non-Executive Independent Director · since 2013
Senior Non-Executive Independent Director · since 2018
Veronica France
Non-Executive Independent Director · since 2013
Mark Hesketh
Non-Executive Independent Director · since 2018
Headquarters & legal address
2ND FLOOR
33-34 WINCKLEY SQUARE
PRESTON, LAN PR1 3JJ
GB
33-34 WINCKLEY SQUARE
PRESTON, LAN PR1 3JJ
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||